Our results suggest that expression of CD206, CD163, CCL2 and TGFβ is high in IPF patients as compared to a chronic inflammatory condition that does not progress to fibrosis, hypersensitivity pneumonitis (Fig 7). The gene discussed is CCL2; the disease is hypersensitivity pneumonitis.